Mirexa Capital was created to better service clients in constantly evolving markets – both in terms of regulatory changes and as traditional market participants change the way that they operate.  The company’s team has experience operating in various trading, sales and research roles in a wide range of financial institutions.

The company provides liquidity in all major cash and derivative asset classes, focusing on the foreign exchange, credit, and interest rate markets. Its global institutional clients include hedge funds, asset managers, central banks and private banks. The company is active in over-the-counter (OTC) and exchange-listed products. Mirexa Capital benefits from TrueQuote and CrossTrade, multi asset electronic solutions for the buy side.

Mirexa Capital is part of TP ICAP group which manages a portfolio of businesses, providing intermediary services, contextual insights and intelligence, trade execution solutions, and data and analytics. For further information on TP ICAP please visit www.tpicap.com.